Episode 65
🧬 Shekhar Mitra - InnoPreneur & P&G - Part 2 | Columbia & Yale: Collaborating with Top Physicists | Moving from Academia to Procter & Gamble | Navigating Challenges, Celebrating Successes | Leading Clinical Trials & Working with the FDA
Part 2 of 4. My guest for this week’s episode is Shekhar Mitra, former Senior Vice President of Global Innovation and Chief of Innovation at Procter & Gamble and current President and Founder of InnoPreneur, a strategic advisory firm that enables development of innovation capabilities, ideation, and organizational development for Fortune 500 corporations and new ventures. Prior to InnoPreneur, Shekhar spent 29 years at Procter & Gamble where he worked his way up from staff scientist to Senior Vice President of Global Innovation and Chief of Innovation, becoming a part of P&G's top leadership team and a member of the CEO's Global Leadership Council. Shekhar’s time at P&G paints a successful entrepreneurial road map for those looking to learn, grow, and innovate within large corporations.
The Biotech Startups Podcast · Excedr
August 1, 202451m 54s
Audio is streamed directly from the publisher (media.fame.so) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.
Part 2 of 4.
My guest for this week’s episode is Shekhar Mitra, former Senior Vice President of Global Innovation and Chief of Innovation at Procter & Gamble and current President and Founder of InnoPreneur, a strategic advisory firm that enables development of innovation capabilities, ideation, and organizational development for Fortune 500 corporations and new ventures.
Prior to InnoPreneur, Shekhar spent 29 years at Procter & Gamble where he worked his way up from staff scientist to Senior Vice President of Global Innovation and Chief of Innovation, becoming a part of P&G's top leadership team and a member of the CEO's Global Leadership Council. Shekhar’s time at P&G paints a successful entrepreneurial road map for those looking to learn, grow, and innovate within large corporations.
Post retirement from P&G, Shekhar spent several years as a board member and strategic adviser to several Fortune 500 corporations, new ventures, and private equity companies developing transformational new ideas, business strategies, and organization capabilities to drive growth.
Join us this week and hear about:
- Shekar’s time at Columbia and Yale collaborating with top-notch physicists, and his involvement in the Jane Coffin Fellowship
- His move from Academia and laser light studies to Procter & Gamble
- Navigating the challenges, failures, and successes along the way
- His experience leading key clinical investigations and working with the FDA
Shekhar’s an expert with an exceptional track record in creating and developing game changing technology platforms and formulating disruptive innovation strategies, whose extensive background in R&D offers unique insights that listeners can benefit from. Please enjoy my conversation with Shekhar Mitra.
Timestamps:
00:28 Intro
01:46 From Colombia to Yale, the Jane Coffin Fellowship, and help from grants and Professors
06:02 Collaborating with top-notch physicists; on track to become a faculty member
10:18 Lessons in innovation breakthroughs and the importance of multi-functional teams
13:10 Leaving academia for Procter & Gamble
18:50 P&G’s impressive research and enzyme engineering prowess; the application of research in everyday life
23:26 Navigating challenges and successes at Procter & Gamble
30:34 Learning from mistakes and getting encouragement at the right moment
34:00 Collaborating with Barry Marshall, Nobel Laureate, and leading clinical investigations 37:37 The importance of having the opportunity to take big swings in research
41:52 Consumer is the boss, but so is the FDA: Shekhar’s experience working with the agency
47:29 The value of listening to and empathizing with those around you
50:48 Outro
Find Our Guest, Shekhar Mitra, at this link:
Find Our Host, Jon Chee, at these links:
Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Enriched Notes:
Topics Mentioned:
Columbia University: https://www.columbia.edu/
Yale University: https://www.yale.edu/
Procter & Gamble: https://us.pg.com/
Jane Coffin Fellowship: https://www.jccfund.org/
Hammett Award: https://www.chem.columbia.edu/content/graduate-awards
Enzyme Engineering: https://www.sciencedirect.com/topics/engineering/enzyme-engineering
X-ray Crystallography: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1186895/
Computational Biology: https://cbd.cmu.edu/about-us/what-is-computational-biology.html
Bioinformatics vs. Computational Biology: https://www.excedr.com/blog/what-is-bioinformatics-and-computational-biology
Protein Folding: https://www.ncbi.nlm.nih.gov/books/NBK9843/
Nobel Prize for Physiology or Medicine, 2005 (Barry Marshall): https://www.nobelprize.org/prizes/medicine/2005/7693-the-nobel-prize-in-physiology-or-medicine-2005-2005-6/
People Mentioned:
Richard Bersohn: https://en.wikipedia.org/wiki/Richard_Bersohn
Don Prothero: https://en.wikipedia.org/wiki/Donald_Prothero
Barry Marshall: https://www.britannica.com/biography/Barry-J-Marshall
John Pepper: https://www.linkedin.com/in/john-pepper-b0a80868/
Jon Moeller: https://us.pg.com/leadership-team/jon-moeller/
The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.